Skip to main content

THOR INVESTMENT MANAGEMENT INC /OH/ /ADV

Position in BIIB — Biogen Inc.

CIK 883734 CINCINNATI, OH

Position in BIIB

as of Jun 30, 2026 · filed Jul 23, 2026
Position Value
$2,161,032
+$342,216 QoQ
Shares Held
10,002
+0.8% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
2.10%
of 13F equity value
Holder Rank
#334
of 1,031 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BIIB Over Time

Shares Held

Position Value (USD)

Derivatives in BIIB

reported options exposure · as of Jun 30, 2026
CallValue
$21,606
CallShares
100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

THOR INVESTMENT MANAGEMENT INC /OH/ /ADV holds $10,964,231 across 3 Drug Manufacturers - General names. BIIB ranks #3 (19.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 BIIB
Biogen Inc.
This page
10,002 $2,161,032

All Filings in BIIB

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,161,032 10,002
2026-06-30 $21,606 100
2026-03-31 $1,818,816 9,921
2026-03-31 $18,333 100
2025-12-31 $1,463,180 8,314
2025-12-31 $17,599 100
2025-09-30 $1,153,979 8,238
2025-06-30 $909,146 7,239
2025-03-31 $1,501,271 10,971
2024-12-31 $1,371,692 8,970
2024-09-30 $1,688,346 8,710
2024-06-30 $1,863,137 8,037
2024-03-31 $1,604,287 7,440
2023-12-31 $25,877 100
2023-12-31 $1,814,754 7,013